← back to search

David Klenerman

UK Dementia Research Institute · GB
Area of research
Physiology · Biophysics
Research interest
Research interests include Chemistry, Biophysics, Cell biology, Biology, Alpha-synuclein, and Intracellular.
h-index
citations
3,762
works
24
NIH funding
primary concept
email

Recent publications

Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease
Alzheimer s & Dementia 2025cited by 25position: lastdoi
Detection of p53 aggregates in plasma of glioma patients
Communications Medicine 2025cited by 5position: lastdoi
Quantitative Profiling of Nanoscopic Protein Aggregates Reveals Specific Fingerprint of TDP‐43‐Positive Assemblies in Motor Neuron Disease
Advanced Science 2025cited by 1position: lastdoi
APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia
EMBO Molecular Medicine 2024cited by 18position: middledoi
Single-molecule characterization of salivary protein aggregates from Parkinson’s disease patients: a pilot study
Brain Communications 2024cited by 4position: lastdoi
Characterization of full-length p53 aggregates and their kinetics of formation
Biophysical Journal 2022cited by 8position: lastdoi
Single-molecule visualization of DNA G-quadruplex formation in live cells
Nature Chemistry 2020cited by 368position: middledoi
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
Cell Death and Differentiation 2020cited by 298position: middledoi
Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death
Communications Biology 2020cited by 102position: lastdoi
ThX – a next-generation probe for the early detection of amyloid aggregates
Chemical Science 2020cited by 80position: middledoi
Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage‐gated calcium channels and NADPH oxidase
FEBS Journal 2020cited by 73position: middledoi
α-Synuclein strains target distinct brain regions and cell types
Nature Neuroscience 2019cited by 326position: middledoi
Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
Science Advances 2019cited by 159position: middledoi
ThX – A next-generation probe for the early detection of amyloid aggregates
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 3position: middledoi
FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions
Cell 2018cited by 930position: middledoi
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
Nature Communications 2018cited by 501position: middledoi
The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity
Journal of Biological Chemistry 2018cited by 139position: middledoi
Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub
eLife 2018cited by 124position: middledoi
Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers
Cell Reports 2018cited by 76position: middledoi
Ca2+ is a key factor in α-synuclein-induced neurotoxicity
Journal of Cell Science 2016cited by 190position: middledoi
Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein
Scientific Reports 2016cited by 68position: lastdoi
Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
Biochemistry 2014cited by 99position: lastdoi
Single Molecule Characterization of the Interactions between Amyloid-β Peptides and the Membranes of Hippocampal Cells
Journal of the American Chemical Society 2013cited by 81position: lastdoi
Amyloid-β Oligomers are Sequestered by both Intracellular and Extracellular Chaperones
Biochemistry 2012cited by 84position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Christopher M. Dobson · University of Cambridge9 papers (2012–2020)Mark R. Wilson · University of Wollongong5 papers (2012–2019) · 5 papers (2014–2020)Sonia Gandhi · Lancashire Teaching Hospitals NHS Foundation Trust5 papers (2016–2020)Mathew H. Horrocks · University of Edinburgh5 papers (2016–2020)Clare Bryant · University of Dundee4 papers (2016–2022)Peter St George‐Hyslop · University Health Network4 papers (2013–2020) · 4 papers (2016–2020)Evgeny V. Pavlov · New York University4 papers (2016–2020)Daniel R. Whiten · University of Wollongong4 papers (2018–2019)Jason C. Sang · UK Dementia Research Institute3 papers (2016–2022)Steven F. Lee · Palo Alto University3 papers (2019–2020)Lisa-Maria Needham · University of Leicester3 papers (2019–2020)Dorothea Böken · UK Dementia Research Institute3 papers (2025–2025)Priyanka Narayan · National Institutes of Health3 papers (2012–2014) · 3 papers (2016–2020)Yunzhao Wu · UK Dementia Research Institute3 papers (2022–2025)Juan A. Varela · University of Colorado Boulder3 papers (2018–2020)Craig D. Hughes · AstraZeneca (Singapore)3 papers (2016–2020)Emre Fertan · Dalhousie University3 papers (2024–2025)